COMMUNIQUÉS West-GlobeNewswire

Crown Bioscience annonce les résultats du deuxième trimestre et nomme le Dr Yangzhou Wang en qualité de Vice Président senior de Global Operations

14/08/2017 - 17:01

SANTA CLARA, Californie, le 14 août 2017 (GLOBE NEWSWIRE) - Crown Bioscience , filiale en propriété exclusive de Crown Bioscience International (TWSE : symbole boursier 6554) et société internationale de services de [...]

Medtronic Announces Randomized Global Resolute Onyx(TM) DES One-Month Dual Antiplatelet Therapy Study to Address Critical Unanswered Question in Interventional Cardiology

14/08/2017 - 15:30

First-of-its-Kind Randomized Clinical Trial Will Evaluate One-Month DAPT in Patients Following PCI Procedures with the Newer-Generation Durable Polymer Resolute Onyx DES DUBLIN- August 14, 2017 - Medtronic plc (NYSE: [...]

Trading in Novo Nordisk shares by board members, executives and associated persons on 11 August 2017

14/08/2017 - 15:01

Bagsværd, Denmark, 14 August 2017 - This document discloses the data of the transaction(s) made in Novo Nordisk shares by the company's board members, executives and their associated persons in accordance with Article [...]

Taconic Biosciences Announces Partnership With Cergentis B.V. to Provide Transgene Mapping Services

14/08/2017 - 15:00

HUDSON, N.Y., Aug. 14, 2017 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in genetically engineered mouse models and associated services, announced it has signed a collaborative agreement with Cergentis B.V [...]

Novo Nordisk A/S - Share repurchase programme

14/08/2017 - 14:53

Bagsværd, Denmark, 14 Aug 2017 - On 2 February 2017, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 ( [...]

Ossur Hf : Major shareholder announcement

14/08/2017 - 11:35

Enclosed notification of a major shareholder announcement Major Shareholder Announcement This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients. The issuer [...]

Completion of the initial public offering of American Depositary Shares and registration of capital increase

14/08/2017 - 09:29

Company announcement - No. 35/2017 Zealand Pharma A/S has today registered a capital increase of 4,375,000 new shares and completed its initial public offering of American Depositary Shares on the Nasdaq Global Select [...]

William Demant Holding A/S: Interim Report 2017

14/08/2017 - 08:01

Company announcement no 2017-07 Interim Report 2017 14 August 2017 Market share gains in wholesale of hearing aids, with organic growth of 11% driven by Oticon Opn Group organic growth of 8% due to innovative products [...]

Saniona AB: Saniona's partner, Luc Therapeutics, nominates clinical candidate and initiates preclinical development in joint Ataxia program

14/08/2017 - 08:00

PRESS RELEASE 14 August 2017 Saniona, a leading biotech company in the field of ion channels, today announces that its collaboration partner, Luc Therapeutics, has initiated preclinical development for the drug [...]

Targovax ASA: Invitation to second quarter and first half 2017 results presentation Thursday 24 August

14/08/2017 - 07:00

Oslo, Norway, 14 August 2017 - Targovax ASA (OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target solid tumors, will announce its second quarter and first half 2017 results on [...]

Corbion reports transactions under its current share buyback program

14/08/2017 - 07:00

Corbion has repurchased 49,850 of its own common shares in the period from August 7, 2017 up to and including August 11, 2017 at an average price of € 25.87 per share. The consideration of the repurchase was € 1.29 [...]

Crown Bioscience Announces Second Quarter Results, Appoints Dr. Yangzhou Wang as Sr. VP of Global Operations

14/08/2017 - 06:00

SANTA CLARA, Calif., Aug. 14, 2017 (GLOBE NEWSWIRE) -- Crown Bioscience , a wholly-owned subsidiary of Crown Bioscience International (TWSE: ticker 6554) and a global drug discovery and development services company [...]

Sanofi : Disclosure of trading in own shares

11/08/2017 - 19:09

Disclosure of trading in own shares This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients. The issuer of this announcement warrants that they are solely [...]

Sanofi : Déclaration des transactions sur actions propres

11/08/2017 - 19:09

Déclaration des transactions sur actions propres This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients. The issuer of this announcement warrants that they [...]

RAMSAY GENERALE DE SANTE : AMENDEMENT ET EXTENSION DE LA CONVENTION DE CREDIT SENIOR

11/08/2017 - 17:35

Paris, le 11 août 2017 « Communiqué de Presse » Ramsay Générale de Santé Amendement et extension de la convention de crédit senior Ramsay Générale de Santé, leader de l'hospitalisation privée en France a finalisé avec [...]

RAMSAY GENERALE DE SANTE : AMEND AND EXTEND OF ITS SENIOR FACILITIES AGREEMENT

11/08/2017 - 17:35

Paris, 11th August 2017 « Press Release » Ramsay Générale de Santé Amend and Extend of its Senior Facilities Agreement Ramsay Générale de Santé, the leading private hospital group in France, on 11 August 2017 [...]

ProMIS Neurosciences Announces Second Quarter 2017 Results

11/08/2017 - 13:30

TORONTO and CAMBRIDGE, Mass., Aug. 11, 2017 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (" ProMIS " or the " Company "), a company focused on the discovery and development of precision treatments for [...]

PCI Biotech: First patient dosed in the fimaCHEM Phase I extension study

11/08/2017 - 08:00

Oslo, 11 August 2017 - PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company, today announced that the first patient has been dosed in the fima Chem Phase I extension study with the objective to evaluate [...]

Notice of Nexstim Plc's Half-Yearly Report H1 2017

11/08/2017 - 08:00

Company announcement, Helsinki, 11 August 2017 at 9:00 am Nexstim Plc (NXTMH:HEX, NXTMS:STO) (" Nexstim " or " Company "), a medical technology company developing and marketing pioneering navigated non-invasive brain [...]